Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Stock-Based Compensation  
Schedule of stock-based compensation expense

   

2022

   

2021

Research and Development

$

32,620

$

71,586

General and Administrative

183,301

145,359

Total Stock-Based Compensation Expense

$

215,921

$

216,945

Schedule of weighted average assumptions

Risk-Free Interest Rate

    

2.42

%

Expected Life (years)

 

5.00

Expected Stock Price Volatility

 

140

%

Expected Dividend Yield

 

%

Schedule of stock option activity

Weighted-Average

Number of

Weighted- Average

Remaining

   

Options

   

Exercise Price

   

Term in Years

Outstanding at December 31, 2021

 

515,922

$

10.43

 

8.30

Granted

 

260,500

$

0.76

 

9.84

Expired

 

(12,662)

$

6.87

Forfeited

(85,610)

$

2.79

Outstanding at March 31, 2022

 

678,150

$

7.85

 

8.55

Exercisable and vested at March 31, 2022

 

241,683

$

18.57

 

2.30

Schedule of restricted stock activity

Number of

Weighted- Average

   

Units

   

Grant Date Fair Value

Non-vested at December 31, 2021

 

15,012

$

6.55

Vested

 

(9,079)

$

6.55

Forfeited

(3,350)

$

6.55

Non-vested at March 31, 2022

 

2,583

$

6.55